Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response

Background: Few studies have provided real-world evidence of mepolizumab efficacy and safety. We aimed to evaluate mepolizumab for severe eosinophilic asthma in daily clinical practice. Research design and methods: Patients included in the RINOVA (Interdisciplinary Network for the management of seve...

Celý popis

Podrobná bibliografie

Vydáno v:	Expert review of respiratory medicine Ročník 13; číslo 12; s. 1205 - 1212
Hlavní autoři:	Caminati, Marco, Cegolon, Luca, Vianello, Andrea, Chieco Bianchi, Fulvia, Festi, Giuliana, Marchi, Maria R, Micheletto, Claudio, Mazza, Francesco, Tognella, Silvia, Senna, Gianenrico
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Taylor & Francis 02.12.2019
Témata:	asthma network eosinophils mepolizumab real-world evidence Severe asthma eosinophils real-world evidence Severe asthma mepolizumab asthma network
ISSN:	1747-6348, 1747-6356, 1747-6356
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!